Prediction of pathologic upgrading in Gleason score 3+4 prostate cancer: Who is a candidate for active surveillance?

PURPOSE: Whether active surveillance (AS) can be safely extended to patients with Gleason score (GS) 3+4 prostate cancer is highly debated. We examined the incidence and predictors of upgrading among patients with GS 3+4 disease. MATERIALS AND METHODS: The study involved 377 patients with biopsy GS...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Investig Clin Urol
Hlavní autoři: Pham, Duc Minh, Kim, Jung Kwon, Lee, Sangchul, Hong, Sung Kyu, Byun, Seok-Soo, Lee, Sang Eun
Médium: Artigo
Jazyk:Inglês
Vydáno: The Korean Urological Association 2020
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7329648/
https://ncbi.nlm.nih.gov/pubmed/32665997
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4111/icu.2020.61.4.405
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky